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Abstract
Several case-control studies have been conducted that examine the association between autonomic
variables and persistent pain conditions; however, there is a surprising dearth of published studies
in this area that have focused on temporomandibular disorders (TMD). The current study presents
autonomic findings from the baseline case-control study of the OPPERA (Orofacial Pain:
Prospective Evaluation and Risk Assessment) cooperative agreement. Measures of arterial blood
pressure, heart rate, heart rate variability, and indirect measures of baroreflex sensitivity were
assessed at rest and in response to a physical (orthostatic) and psychological (Stroop) stressors in
1633 TMD-free controls and 185 TMD cases. In bivariate and demographically adjusted analyses,
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greater odds of TMD case status were associated with elevated heart rates, reduced heart rate
variability, and reduced surrogate measures of baroreflex sensitivity across all experimental
procedures. Principal component analysis was undertaken to identify latent constructs revealing
five components. These findings provide evidence of associations between autonomic factors and
TMD. Future prospective analyses in the OPPERA cohort will determine if the presence of these
autonomic factors predicts increased risk for developing new onset TMD.
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There is considerable evidence that enhanced pain sensitivity and psychological distress are
risk factors1 for the onset and maintenance of temporomandibular joint disorders (TMD; for
reviews see Maixner et al. in this volume, Diatchenko et al19 and Maixner59). In addition to
these relatively well studied risk domains, emerging evidence indicates that dysregulation of
the autonomic nervous system contributes to the onset and persistence or chronicity of TMD
and related conditions.8, 10, 16, 52, 57, 59, 83 To date only a handful of studies have
systematically examined and compared autonomic function in TMD cases and controls
under resting conditions and in response to physical and psychological
stressors.8, 10, 16, 52, 81, 83 However, there is a rather substantial literature on the autonomic
profiles associated with fibromyalgia syndrome (FMS), a chronic musculoskeletal condition
where over 50% of affected people also experience chronic TMD.22, 53, 54, 60–62, 68 Some
individuals with FMS display autonomic dysregulation that involves increased sympathetic
nervous system (SNS) drive at rest coupled with deficient SNS-mediated responses to
specific challenges such as postural change or exercise.28, 60, 62 Decreased heart rate
variability (HRV) under awake resting conditions and during sleep is seen in FMS and is
consistent with lesser parasympathetic and greater β-adrenergic tone.13, 62, 68 Arterial
baroreflexes, a brain stem system that is involved in regulating cardiovascular dynamics and
pain perception, is also blunted in individuals with FMS.7, 37, 60, 79
Consistent with blunted baroreflex sensitivity, people with FMS show reduced heart rate
(HR) and blood pressure (BP) responses during orthostatic challenges.7, 26 Further evidence
for a central nervous system (CNS) dysregulation in autonomic function in FMS patients is
the finding of reduced plasma epinephrine (EPI) and norepinephrine (NE) responses, as well
as decreased NE metabolites in cerebrospinal fluid, to stressors such as exercise or
hypoglycemia.28, 31, 48, 92 Compared to controls, individuals with TMD express lower
ambulatory BP than controls16 and reduced plasma NE levels at rest and during a public-
speaking stressor procedure. 15, 52 Thus, an emerging literature implicates a CNS-mediated
dysregulation of autonomic function at rest and in response to both physical and
psychological stressors. This dysregulation contributes to the clinical signs and symptoms
seen in patients with FMS, suggesting that it may also contribute to the signs and symptoms
of TMD.
One aim of baseline case-control study of the OPPERA project (Orofacial Pain: Prospective
Evaluation and Risk Assessment) was to assess autonomic profiles of people diagnosed with
TMD arthralgia, myalgia or both (“TMD cases”) and people who were found not to have
TMD when examined (“controls”). Autonomic profiles were measured under resting
1Here, we define a risk factor as “An attribute or exposure that is associated with an increased probability of a specified outcome, such
as the occurrence of a disease. Not necessarily a causal factor.” 46
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conditions and in response to a physical stressor (i.e., orthostatic challenge) and a
psychological/cognitive stressor (i.e., Stroop color-word and pain-word tests).
Methods
Study setting and participants
As described elsewhere (see Slade et al. in this volume for detailed description) the
OPPERA baseline case-control study used advertisements, emails, flyers, and word of
mouth to recruit people who had chronic TMD (“cases”) and people who did not
(“controls”). They were recruited between May 2006 and November 2008 from
communities in and around academic health centers at four US study sites: Baltimore, MD;
Buffalo, NY; Chapel Hill, NC; and Gainesville, FL. At each study site, the target was to
recruit 800 controls and variable numbers of cases based on local operational requirements,
for a total of 3,200 controls and 200 cases. The actual number enrolled was 3,263 controls
and cases.
The classification of TMD was based on the Research Diagnostic Criteria for
Temporomandibular Disorder.18 In summary, cases met all three of the following criteria:
during the telephone interview, (i) pain reported with sufficient frequency in the cheeks, jaw
muscles, temples, or jaw joints during the preceding six months (at least 15 days in the
preceding month and at least five days per month in each of the five months preceding that);
during the examination, (ii) pain reported in the examiner-defined orofacial region for at
least 5 days out of the prior 30 days; and (iii) pain reported in at least three masticatory
muscles or at least one temporomandibular joint in response to palpation or to maneuvering
of the jaw. Examiners defined the orofacial region by touching the following anatomical
areas bilaterally: temporalis, preauricular, masseter, posterior mandibular, and
submandibular. Controls met all five of the following criteria: during the telephone
interview, (i) pain reported infrequently in the cheeks, jaw muscles, temples, or jaw joints
(no orofacial pain in the preceding month and no more than four days per month in any of
the five months preceding that); (ii) no more than four headaches per month within the
preceding three months; (iii) never diagnosed with TMD; (iv) no use of a night guard
occlusal splint; and during the examination, (v) pain reported in the examiner-defined
orofacial region for no more than 4 days in the prior 30 days. However, controls could be
positive or negative with respect to pain in response to palpation or jaw maneuver.
Additional study-wide criteria for all study participants were aged 18–44 years, fluent in
English, not receiving orthodontic treatment, and not pregnant or nursing, and had negative
responses to each of 10 questions about significant medical conditions and no history of
facial injury or surgery.
This analysis uses data from all 185 recruited TMD cases and one half of the 3,263 recruited
controls (1,633 people). The controls for this analysis were selected at random so that data
from people in the reserved sample could be used for validation studies that will be reported
elsewhere. The accompanying paper (see Slade et al., in this volume) gives a more detailed
account of study recruitment, case-classification methods, and inclusion and exclusion
criteria.
Ethical conduct of research with humans
The OPPERA study was reviewed and approved by institutional review boards at each of
the four study sites and at the data coordinating center, Battelle Memorial Institute. All study
participants verbally agreed to a screening interview done by telephone and they provided
written consent for all other study procedures.
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During the 3-hour baseline clinic visit, autonomic profiles were measured for all participants
in five periods: (1) a 20-minute rest period that followed the clinical examination; (2) a 5-
minute orthostatic challenge period that followed Period 1; (3) a 10-minute rest period that
followed assessments of thermal and mechanical pain sensitivity, (4) a period of
approximately 5 minutes following Period 3, during which the traditional Stroop Color-
Word test was administered, and (5) a period of approximately 5 minutes following Period
4, during which the Stroop Pain-Affect test was administered2.
At the beginning of the first period, a blood pressure cuff, which completed a single reading
in approximately 35 seconds, was placed on the upper left arm and was inflated with a
Datascope Accutorr Plus blood pressure monitor (Datascope Inc, Mahwah, NJ). HRV was
assessed with a three lead BioCom model 3000 Heart Rhythm Scanner (Biocom
Technologies. Poulsbo, WA) with the electrical leads positioned at the following locations:
left 2nd rib (ground), right 2nd rib, and lower left torso. ECG signals were checked for
impedance (below 300 KOhm), digitized (1024 samples per second), filtered for artifacts3,
and displayed in real-time on a laboratory computer. Participants could not see the
instruments’ displays. Participants were placed in a zero-gravity exam chair
((http://sitincomfort.com/zerrec.html) and fully reclined (supine position) in a room with
soft lighting. Once the participant was reclined, they were read the following instructions:
“During this rest period, please stay quiet and remember not to cross your legs even
at the ankles. I will let you know when the rest period is complete but I cannot talk
to you during the rest period.”
Blood pressure ((BP)—systolic (SBP) and diastolic (DBP)—mean (MAP) pressures), and
HR measures were assessed every 2.5 minutes for 20 minutes.
At the beginning of the second period, participants were provided with the following
instructions:
“Now I am going to ask you to stand up as quickly as you can but first please listen
to my instructions. I am going to count to 3 and I would like you to use your right
arm to help yourself out of the chair and stand up with both feet flat on the floor. It
is very important that you stand up as fast as you can. If you should happen to feel
dizzy or lightheaded let me know and remember the chair will be behind you. Do
you have any questions?”
BP and HR were recorded within 30 seconds of standing and BP and HR measures were
obtained at 1 minute intervals for the next 5 minutes. HRV was assessed over the duration of
the 5 minute orthostatic period.
For Periods 3, 4, and 5, participants were positioned in a chair facing a computer with four
buttons colored yellow, green, blue, and red. Following the 10 minute rest period (Period 3),
and a training period with the computer, participants were exposed to a 5-minute
2The results associated with the QST aspects (thermal, pressure, mechanical) of the protocol are reported elsewhere in this
compendium (see: Greenspan, et al. Pain Sensitivity Risk Factors for Chronic TMD: Descriptive Data and Empirically Identified
Domains from the OPPERA Case Control Study. Because of time constraints associated with the protocol, autonomic testing was not
performed during the administration of painful stimuli.
3Noise free, real-time signals were first documented by the technician to assure that traces with very sharp R-peaks were being
recorded. Software intrinsic to the device detected the near proximity of the R-peak and values that deviated by more than 30% of the
normal previous normal heart rate reading were tagged and rejected. The software is also capable of detecting various types of
abnormal heartbeats resulting from several causes. The following statistical steps were performed by the device implemented to assess
and reject artifacts: 1) Linear trends were removed from the HR data record, 2) mean HR and standard deviation of HR was calculate
and 3) each HR reading was tested to determine if it belonged to the normal HR data pool based on the Student t-test. Abnormal or out
of range HRs were visually tagged and removed from the analysis.
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computerized version of the Stroop Color-Word task86 Weisseman-Fogel and coworkers91
have shown that TMD patients show abnormal cortical activity evoked by the type of
cognitive and emotional STROOP stimuli used in this study. (Period 4). Participants were
told “During this procedure, the words YELLOW, GREEN, BLUE, or RED appear on the
screen in the colors yellow, green, blue or red in a randomly assigned manner.” The
participant was instructed to press the button corresponding to the color of the word
displayed on the screen (e.g., if the word RED appeared in yellow the correct response was
to depress the yellow key). During Period 5, the Stroop Pain-Affect task was
administered.71. Words with different psychological valances [i.e., neutral words (garden,
armchair) vs. words associated with pain and affect (throbbing, miserable)] appeared in the
colors yellow, green, blue, or red and the participant’s task was to press the button
corresponding to the color of the word displayed on the screen (e.g., if the word BLOOD
appeared in green the correct response was to depress the green key). The sequence of word
presentation and tabulation of results was done using DirectRT hardware and software
(Empirisoft, NY, NY). Throughout Periods 3, 4, and 5, BP and HR values were assessed at
1-minute intervals. HRV was recorded continuously during each of the 5-minute Stroop
procedures. The autonomic measures were averaged over the 5 minute Color and the 5-
minute Pain-Affect Stroop epoch.
Derived Autonomic Measures
Measures of Arterial Blood Pressure and Heart Rate—BP values were recorded in
mmHg and MAP was derived using the following formula: MAP = (SBP + 2*DBP)/3. Heart
rate was measured coincidence with measures of arterial BP in beats-per-minute (bpm).
Measures and Analyses of HRV—For reviews on the measurement and interpretation
of HRV variables see the recommendations provided by the Task Force of the European
Society of Cardiology and the North American Society of Pacing and Electrophysiology1
and by Berntson et al.6 Time Domain Measures: Heart Rate was measured as inter-beat-
intervals and a reciprocal value was calculated to derive HR values as beats-per-min (bpm).
SDNN (standard deviation of normal-to-normal [N-N] intervals) is the standard deviation of
cardiac cycle inter-beat intervals, measured in milliseconds, and it reflects all cyclic
components of the variability in the recorded series of inter-beat-intervals. RMSSD (root
mean square of the differences between successive N-N intervals) is the square root of the
mean squared differences of successive inter-beat-intervals, measured in milliseconds, and is
an estimate of high-frequency variations in heart rate in short-term recordings that reflects
an estimate of parasympathetic regulation of the heart. Frequency Domain Measures: Total
Power (TP) is a short-term estimate of the total power of power spectral density in the range
of frequencies between 0 and 0.4 Hz. This measure reflects overall (cardiosympathetic and
cardioparasympathetic) autonomic activity. Very Low frequency (VLF) is a band in the
power spectrum ranging between 0.0033 and 0.04 Hz. This measure is not well defined in
terms of physiological mechanisms; however, activity in this frequency band has been
associated with regulation of the renin-angiotensin system and used as an indicator of
activity of slow temporal processes regulated by the sympathetic nervous system. Low
Frequency (LF) is a band of the power spectrum that ranges between 0.04 and 0.15 Hz and
reflects both sympathetic and parasympathetic activity. It is a strong indicator of
sympathetic activity in long-term recordings. Parasympathetic influence is represented in the
LF band when respiration rate is lower than seven breaths per minute or during a valsalva
procedure. Thus, when a participant is in the state of relaxation with a slow and even
breathing, LF values are indicative of increased parasympathetic activity rather than
increased sympathetic regulation. Activity in the LF band has also been related to baroreflex
sensitivity with higher values associated with greater baroreflex sensitivity.12, 72, 82, 88, 89
Greater baroreceptor sensitivity produces greater reflex changes in HR for a given change in
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MAP and is associated with enhanced baroreflex cardioparasympathic responses to a given
change in mean arterial pressure. High Frequency (HF) is a band of the power spectrum
that ranges between 0.15 and 0.4 Hz and reflects parasympathetic activity. HF is also known
as a respiratory band because it corresponds to the inter-beat-interval variations influenced
by respiratory sinus rhythm. Slower and even breathing causes an increase in
cardioparasympathetic activity and the amplitude of the HF peak in the power spectrum.
Frequency domain measures are calculated in milliseconds squared (ms2).
Data Analysis
HRV Data—For time domain parameters : Mean HR were excluded if not between 40–200
bpm, Mean RR had to be within 400–2000 ms, SDNN ratings were between 10–500 ms, and
finally RMSSD measures were within the range 10–1000 ms. Frequency domain parameters
had the following limits: Total Power (TP) 10–10,000 ms2, Very Low Frequency (VLF) 10–
6000 ms2, Low Frequency (LF) 10–6000 ms2, and High Frequency (HF) 10–6000 ms2. Only
high-quality ECG signals were collected and subjected to artifact detection and cleaning
using Biocom Heart Rhythm Scanner software (version 2.0). After filtering for out of range
time and frequency domain values, an additional data quality check was performed to assure
that the TP value was greater than the sum of the HF, LF, and VLF values. The frequency
domain measures (TP, HF, LF, VLF) were strongly right-skewed so a logarithmic
transformation was performed on the absolute units of these spectral bands to diminish this
effect.
BP and HR Data—SBP measurements were excluded if outside the range of 60–220
mmHG. DBP measures had to be within 40–110 mmHG. HR measures during the reclined
period had to be between 30–175 bpm. During all other periods, orthostatic, Stroop-baseline,
color-word, pain-affect had to be between 40 and 200 bpm.
For the Rest Period (1), Mean BP measures (SBP, DBP, MAP, and HR) were averaged over
the last three recordings assessed at minutes 15, 17.5, and 20 during the rest period. For the
Orthostatic Period (2), the changes in BP: ΔSBP, ΔDBP, ΔMAP, and ΔHR from the values
obtained during the Rest Period were determined by subtracting the first value measured in
the orthostatic period from the mean values obtained at minutes 15, 17.5, and 20 during the
rest period. For the Stroop Periods (4&5): mean BP measures (SBP, DBP, MAP, and HR)
were averaged over the five minute data collection period at minutes 1:00, 2:00, 3:00, 4:00
and 5:00. Changes in BP: ΔSBP, ΔDBP, ΔMAP, and ΔHR from the pre-Stroop values
(Period 3) were determined by subtracting the average value measured in the pre-Stroop
period at minutes 5:00, 7:30, and 10:00 from the mean of the values obtained during the
Stroop tasks, with values at minutes 1:00, 2:00, 3:00, 4:00 and 5:00 to compute the mean
value.
The ratio of HR÷MAP was computed as a measure of the relative balance of
cardiosympathetic versus cardioparasympathetic (vagal) tone at a given baroreflex set point
(MAP). Higher values reflect greater cardiosympathetic versus cardioparasympathetic tone
while lower values signify greater cardioparasympathetic versus cardiosympathetic tone at a
given baroreceptor set point.2, 35, 90
Imputation for missing values used the EM method in SAS proc MI which finds maximum
likelihood estimates for incomplete data under the assumption that the data are multivariate
normal.80 Descriptive statistics for each summary score were generated using non-imputed
data. Statistical significance of differences in mean scores was evaluated using the t-test
derived from a least squares linear model in which study site was a covariate. Study site was
used as a covariate because operational requirements during recruitment created different
proportions of cases among sites (see Slade for further details). The relationship between
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each summary score and occurrence of TMD was expressed as the standardized odds ratio
(SOR), calculated from an unconditional, binary logistic regression model with study site as
a covariate. To achieve this, the summary score was transformed to a unit-normal deviate.
The transformation meant that odds ratios could be interpreted as the relative change in odds
of TMD for each standard deviation of change in the summary score. A second logistic
regression model generated a fully-adjusted estimate of the relationship, using additional
covariates of age (in years), gender, and race/ethnicity (dichotomized as white or non-
white). A third logistic regression model using this imputed dataset calculated SORs for
each summary score, with adjustment for the same covariates as in the prior model. Odds
ratios with values less than 1.0 were reverse coded for ease of presentation and
interpretation.
All P-values were computed without adjustment for multiple tests, and we therefore refrain
from designating P=0.05 as a threshold for statistical significance. In this paper’s case-
control analysis, up to 15 autonomic variables were investigated for any experimental
condition, Resting epoch assessed 11 variables (Note: blood pressure cuff assessed Mean
HR is equivalent to ECG assessed Mean HR (HRV) and were treated as a single entity for
this calculation), Orthostatic epoch 11 variables, Stroop Color Word epoch 15 variables and
Pain-Affect 15 variables. Therefore, the most conservative Bonferroni correction for the
probability of type I error for a given experimental period would yield a critical P-value of
0.05÷15 = 0.003. Using the same rationale, rejection of the null hypothesis concerning odds
ratios would occur only if the 99.6% confidence interval excluded the null value of one. In
general, though, we avoid drawing conclusions about statistical significance of associations,
even with correction for multiple tests, because these papers report only univariate- or
demographically-adjusted results. Furthermore, the Bonferroni adjustment is probably
overly-conservative in this setting, where several measures are moderately correlated.
Instead, we will reserve judgments about statistical significance to subsequent papers that
will use multivariable modeling to consider multiple characteristics simultaneously, as
proposed in the OPPERA heuristic model (Maixner et al. this volume).
Principal component analysis (PCA) was applied to this data set to identify putative latent
variables. The approach began with four steps, widely used in exploratory principal
component analysis69: 1) variable selection; (2) evaluation of the correlation matrix; (3)
extraction of initial components; and (4) rotation and interpretation of component loadings.
This model is being used for purely exploratory purposes with regards to the structure of the
latent variables and not for computation of summary scores for the various components.
Our primary interest focused on PCA loadings in controls for three reasons: (a) there are
many more controls than cases, thereby improving statistical power to identify factors and
estimate loadings; (b) our underlying conceptual model of TMD (see Maixner et al. in this
volume) proposes that relationships between putative risk factors might alter following onset
of chronic pain, and we wanted to evaluate that possibility; and (c) the long-term goal of
OPPERA is to identify risk factors for TMD among controls, so it is desirable to identify a
reduced set of variables for that group. Thus, we fit separate PCA models for the TMD cases
and controls.
We elected to keep the 42 variables listed in Table 6 in the model even though some of the
variables were highly correlated with one another. We wanted to determine which measures
could be combined into latent variables, and this required that all the variables be retained in
the model. Although this has the potential to increase the variance of our estimates of the
PCA loadings, this was not a major concern given our large sample size. As shown below,
we estimated the variance of our PCA loadings using bootstrapping, and these variances
were uniformly low despite the correlations among the input variables. The only variables
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we did not include in the model were variables derived from two or more of the underived
variables (e.g., HR/MAP Index), since the inclusion of such variables would create both
computational and interpretative difficulties.
After imputing missing values as described above, 348 subjects still had at least one missing
value among the variables included in the model. Because missingness may be non-random,
we were concerned with bias if we dropped these 348 subjects from the model. To avoid this
potential bias, we performed a second round of imputation. Specifically, we imputed any
missing BP measures based on the observed BP measurements in the same epoch and we
imputed missing HR measurements based on the observed HR measures in the same epoch.
We then imputed any remaining missing BP measurements based on observed BP
measurements in other epochs and missing heart measures based on observed HR measures
in other epochs. We used the EM algorithm to perform this imputation under the assumption
that the data are multivariate normal, as described previously. After performing this second
round of imputation, there were only nine remaining subjects with missing data. It should be
noted that we report the SOR’s for both the imputed and unimputed data sets (see Tables 1–
4), and in all cases the results are extremely similar (if not identical). And while we do not
report these results, we also fit our PCA model using only unimputed data, and we obtained
a model very similar to the model reported in the manuscript.
We examined a scree plot to estimate the number of components to include in the model
(Figure 1). The variance explained by each principal component decreased most
conspicuously after the fifth component, suggesting that at least five components are
needed. We used parallel analysis to verify this estimate. Parallel analysis estimates the
number of components to include in a PCA model by generating random data sets with the
same numbers of observations and predictor variables as the original data. The eigenvalues
are computed for each random data set and averaged over all the data sets. When the average
eigenvalue from these randomly generated data sets is larger than the corresponding
eigenvalue of the original data, then the principal component associated with that eigenvalue
is likely to be random noise. The parallel analysis also showed strong evidence that
components one through five were above the chance line (Figure 1). Components six, seven,
and eight were near the chance line, so it was unclear if they should be included in the
model.
We therefore fit PCA models using five, six, seven, and eight components. The bootstrap
confidence intervals for components six, seven, and eight were very wide for many of the
loadings, suggesting that the estimated loadings were unstable. (Data not shown) However,
the confidence intervals for the loadings of the first five components were very narrow,
indicating a stable (and accurate) model. Additionally, the Cronbach’s alpha values for these
five components were very high—ranging from 0.92–0.96—further supporting a good
reliability of this model. Thus, we report a model based on five components.
PCA models were fit using the R statistical computing platform. All variables were
normalized to have mean 0 and standard deviation 1 prior to fitting the models. After
calculating the PCA eigenvectors, a promax rotation was applied to increase the
interpretability of the resulting PCA loadings. The promax rotation produced loadings that
were easier to interpret than the loadings resulting from orthogonal rotations, and other non-
orthogonal rotations produced similar results. The rotated loadings are presented unless
otherwise noted. The variance in the PCA loadings of each model was estimated by drawing
1000 bootstrap samples for each data set and fitting a PCA model for each replicate. The
95% confidence bounds for the PCA loadings were estimated to be the 2.5% and 97.5%
quantiles of the corresponding loading over the 1000 bootstrap replicates.21
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We performed a series of permutation tests to test the null hypothesis that the loadings were
the same for both the control and TMD models, and we found that these differences were
not statistically significant, particularly considering that we are performing multiple
hypothesis tests (Supplementary e-Table 20). It is unclear if the loadings are truly identical
for both models or if we simply do not have power to detect the difference given the
relatively small number of TMD cases. The confidence intervals for the PCA loadings in the
model based on TMD cases are very wide for components 2–5 (Supplementary e-Table 19).
This is not surprising, given that the case sample size was relatively small, but it indicates
that the estimates of these loadings have high variance and may not be reliable.
Results
Case-Control Differences 4
Autonomic Profiles During the 20 min Rest Period- (Table 1)—As shown in Table
1, average DBP and HR (cuff and inter-beat-interval) assessed during the resting period
were greater in cases compared to controls, yielding SORs of 1.2 that did not change
appreciably after adjustment or imputation. Resting measures of SBP and MAP did not
differ between the two groups. The Resting HR÷MAP Index was greater in cases than in
controls, with corresponding SORs of 1.2 (site-adjusted) and 1.1 (fully-adjusted and
imputed). Odds ratios and their 95% confidence intervals were similar with and without
adjustment for missing data (imputed) and demographic characteristics. These finding
suggests that under resting conditions, TMD case and controls have equivalent resting
baroreflex set points (i.e., MAP’s 83.5 + .61 vs 82.8 + .21 mmHG) but due to the elevated
resting HR observed in TMD cases they may have a bias towards greater cardiosympathetic
versus cardioparasympathetic tone compared to controls. HRV measures also differed
between cases and controls. TMD cases showed lower values than controls in both time
(SDNN, RMSSD) and frequency (TP, VLF, LF, HF) domains. Corresponding SORs ranged
from 1.2–1.3 and were similar after adjustment for demographic characteristics. These
findings suggest that under resting conditions, TMD patients show reduced HRV compared
to controls. The reduced power seen in the LF band in cases compared to controls is also
consistent with reduced baroreflex sensitivity, which contributes to the elevations in HR and
bias towards greater cardiosympathetic versus cardioparasympathetic tone observed in
cases.2, 24, 35, 90 The small increase in DBP observed in cases is also consistent with
increased sympathetic drive due to either an increase in peripheral vascular resistance and/or
increased HR both of which can increase arterial tone and diminish arterial relaxation time.
Autonomic Profiles during Orthostatic Challenge – A Physiological Stressor
(Table 2)—Mean changes (Δs) in SBP, MAP, and HR from rest to the first 30 to 60
seconds of the orthostatic challenge were similar for cases and controls (Table 2).
Corresponding change in DBP was marginally greater, on average, in controls compared to
cases, although the SOR was not significant after adjustment for demographic
characteristics. HRV measures also differed between cases and controls with lower values
observed among cases in both the time (SDNN, RMSSD) and frequency (TP, VLF, LF, HF)
domains. Corresponding SORs ranged from 1.1–2.2. Odds ratios and their 95% confidence
intervals were similar with and without adjustment for demographic characteristics. Similar
to the results observed under resting conditions, the orthostatic challenge was associated
with reduced HRV compared to controls and the reduced power seen in the LF band in cases
compared to controls is also consistent with reduced baroreflex sensitivity, which
4A complete description of demographic distributions, including age and gender is contained in the article by Slade, et al in this
Compendium which also reports that 85% of the cases were myalgia + arthralgia, and the remaining 15% was roughly equally
allocated to myalgia alone and to arthralgia alone. Given the relatively small cell sizes associated with the TM-joint and myalgia only
groups we elected to not differentiate the population into multiple subgroups.
Maixner et al. Page 9













contributes to a bias towards greater cardiosympathetic versus cardioparasympathetic tone in
cases during the orthostatic challenge.
Autonomic Profiles During Stroop Procedures – Psychological Stressors –
(Tables 3 and 4)
Stroop Color-Word Procedure: As shown in Table 3, the mean change (Δ) in SBP, MAP,
and HR evoked over the 5-minute Color-Word Stoop, as compared to values recorded
during the pre-Stroop resting period, did not differ between cases and controls. The ΔDBP
response was marginally greater in controls compared to cases and the SOR was 1.2. As
shown in Table 3, cases showed greater HR responses (cuff and inter-beat-interval) averaged
over the 5-minute observational period compared to controls. SBP, DBP and MAP
responses averaged over the same time period did not differ between the two groups.
Standardized odds ratios (SORs) for case status were 1.4 for HR. The Color-Word Stroop
HR÷MAP Index averaged over the same time period was also greater in cases than in
controls, with an SOR of 1.3 that did not change appreciably after adjustment and
imputation. Cases showed lower values for heart rate variability in both time (RMSSD) and
frequency (TP, VLF, LF, HF) domains. Corresponding SORs ranged from 1.2–1.4. Odds
ratios and their 95% confidence intervals were similar with and without adjustment for
demographic characteristics.
Pain-Affect Stroop Procedure: Similar to the Color-Word Stroop test, the mean change
(Δ) in SBP, MAP, and HR evoked over the 5-minute Pain-Affect Stoop, as compared to
values recorded during the pre-Stroop resting period, did not differ between cases and
controls (see Table 4). In contrast to the Stroop Color Word-evoked ΔDBP response, the
Pain-Affect Stroop test evoked a slight reduction in ΔDBP, which was greater in controls
compared to cases (−1.28 + 0.14 vs −0.11 + 0.40; p < 0.008). The corresponding SOR was
1.2, an effect that persisted after adjustment for demographics and after imputation. Average
DBP and HR (cuff and inter-beat-interval) responses were greater in cases compared to
controls over the 5-minute assessment period. In contrast, average SBP and MAP values
collected over this same time period did not differ between the two groups. SORs were 1.2
for DBP and 1.4 for HR. The HR÷MAP Index averaged over the same time period also
differed between the two groups with a higher index observed in cases, and corresponding
SOR of 1.3. Odds ratios and their 95% confidence intervals were similar after adjustment for
demographics and with imputation for missing data. Cases had lower values than controls in
both time (SDNN and RMSSD) and frequency (TP, VLF, LF, HF) domains of heart rate
variability. Corresponding SORs ranged from 1.2–1.4 and were similar with and without
adjustment for demographic characteristics.
These findings suggest that the Color-Word and Pain-Affect Stroop procedures are
associated with reduced HRV in cases compared to controls. The reduced power seen in the
LF band in cases compared to controls is also consistent with reduced baroreflex sensitivity
during the Stroop procedures, which contributes to the elevations in HR and a bias towards
greater cardiosympathetic versus cardioparasympathetic tone observed in cases.
Associations with Demographic Variables (Controls Only)- A Brief Summary
of Findings—A summary of the relationship between demographic variables and
autonomic variables assessed in all four test periods can be found in Table 5. In brief, during
all four procedures, all BP measures were associated with greater age, male gender, and non-
white race—with the single exception of resting DBP. In nearly all procedures, greater HR
was associated with female gender and non-white race, but not with age. The HR÷MAP
index was generally less with greater age and male gender. In most procedures, changes in
BP and HR were either inconsistently related or greater for younger age and male gender. In
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nearly all procedures, all HRV measures were negatively associated with greater age and
they were higher in males than in females. In all procedures, measures of VLF and LF were
greater in whites than non-whites, and in the orthostatic procedure the TP was also greater in
whites than in non-whites. In general, these demographic patterns tended to be stable across
procedures. A detailed description of the relationships between demographic variables and
autonomic variables can be found in Supplementary e-Tables 1–4 (Age), Supplementary e-
Tables 5–8 (Gender), and Supplementary e-Tables 9–12 (Race/Ethnicity).
Distributions of Autonomic Measures—The mean, minimum, and maximum values
and distribution (5th–95th percentiles) for each autonomic variable measured during the Rest
Period (Supplementary e-Table 13), Orthostatic Challenge (Supplementary e-Table 14),
Color-Word Stroop test (Supplementary e-Table 15), and the Pain-Affect Stroop test
(Supplementary e-Table 16) are presented in the e-Supplement.
Principal Component Analysis—The loadings for the PCA model for controls are
shown in Table 6, and the 95% confidence intervals for the loadings are shown in
Supplementary e-Tables 17–19. The confidence intervals are uniformly narrow, indicating
that these results are stable.
The first component, accounting for 18% of the variance, labeled Blood Pressure
Component, includes high loadings from SBP, DBP, and MAP across all protocols (Rest,
Orthostatic, and Stroop). The second component, labeled Stroop HRV, based on high
loadings from both time (with the exception of HR) and frequency HRV domains collected
during both the Color and Pain-Affect Stroop tests accounted for an additional 16% of the
variance. The third component, Heart Rate, accounted for an additional 14% of the variance
and included high loadings for measures of HR across all protocols (Rest, Orthostatic, and
Stroop). The fourth component is labeled Resting HRV and accounted for an additional 12%
of the variance and is based on high loadings from both time (with the exception of HR) and
frequency HRV domains collected during the 20 minute resting period. The fifth component
is labeled Orthostatic HRV and accounted for an additional 10% of the variance and is based
on high loadings from both time (with the exception of HR) and frequency HRV domains
collected during the orthostatic assessment period.
The loadings and 95% confidence intervals for the PCA for TMD cases are shown in
Supplementary e-Table 19. The number of components and associated loadings were similar
to that observed for controls. These confidence intervals are wider than observed for
controls; with the exception of the loadings for the first component, essentially all of the
loadings for the PCA in cases have very wide confidence intervals. This indicates that (with
the exception of component one), this factor structure may not be reproducible. The higher
variance in the loadings of the PCA for TMD cases is probably due to its much smaller
sample size. Despite its high variance, the PCA model for cases was extremely similar to the
model for controls. The differences in the loadings of the two models were generally very
small. We performed a series of permutation tests to formally test the null hypothesis that
these loadings were equal (Supplementary e-Table 20), and we found no evidence of case/
control differences in the loadings (particularly after adjusting for the fact that we performed
multiple hypothesis tests).
Discussion
This is the first large scale case-control study that has systematically examined resting and
stress-evoked autonomic profiles in chronic TMD cases and controls. While the case-control
study design does not ascertain whether change in autonomic activity might be a cause or
consequence of TMD, several of the observed associations provide grounds for further
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investigation of potential etiologic influences of autonomic activity. The primary findings
that have emerged from these initial studies of potential risk factors are:
1. Relative to controls, TMD cases displayed a dysfunction in autonomic activity
characterized by reduced HRV at rest and in response to both physical (orthostatic)
and psychological (Color Word and Pain Affect Stroop tests) stressors. This is
reflected by a decrease in all HRV measures in both the time and frequency
domains during each of the test epochs. Measures of HRV were related to the odds
of case status across all experimental epochs providing SORs ranging from 1.2–2.2.
The largest SOR (2.2 for RMSSD) for case status was associated with the
orthostatic epoch and is a reflection of decreased cardioparasympathetic responses
to the orthostatic challenge.
2. Relative to controls, TMD cases display higher HRs when engaged in physical
(orthostatic) and psychological (Stroop tests) tasks. These findings are consistent
with the HRV results, which showed across all time and frequency domains
reduced cardioparasympathetic tone compared to controls. Measures of HR were
related to odds of case status across all experimental epochs providing SORs
ranging from 1.1–1.4. The largest SOR (1.4) for case status was associated with
both the Color-Word and Pain-Affect Stroop tasks. These findings are consistent
with a central dysregulation which results in a relatively higher cardiosympathetic
tone in cases during resting as well as during physically and psychologically
stressful procedures.
3. Relative to controls, TMD cases displayed a reduction in an indirect index of
baroreceptor sensitivity. This is reflected by a decrease in LF band values at rest
and during the orthostatic and Stroop tasks. Measures of LF were related to the
odds of case status across all experimental epochs providing SORs ranging from
1.2–1.4. The largest SOR (1.4) for case status was associated with the orthostatic
epoch. The putative reduction in baroreceptor sensitivity is consistent with the
reduction in HRV measures of cardioparasympathetic tone and the bias towards
greater cardiosympathetic tone in TMD cases relative to controls.
4. The results of the PCA suggest that BP (Component 1) and HR (Component 3)
measures tend to be strongly correlated across the various epochs, but HRV
measurements (Components 2, 4, and 5) tend to be less correlated across different
epochs. Thus, measuring a subject’s BP or HR during an orthostatic challenge or
Stroop test may provide minimal additional information if their resting BP/HR is
known, but the HRV measurements taken during the physical and psychological
challenges may contain more information beyond the information obtained by
measuring the HRV at rest.
5. Age, Gender, and Race/Ethnicity autonomic profiles showed that in general higher
BP measures were associated with greater age, male gender, and non-white race.
Greater HR was associated with female gender and non-white race, but not with
age. The HR÷MAP index was smaller with greater age and male gender. In nearly
all procedures, all HRV measures were negatively associated with greater age and
they were higher in males than in females.
Heart Rate Variability – TMD and Related Conditions
Coupled with the findings we present here, there is emerging evidence that somatosensory
disorders such as TMD and FMS are associated with a reduction in HRV (i.e. TP, HF, LF,
VLF bands) and an overall dysfunction in autonomic activity.10, 13, 78, 79, 81, 83 To date, only
a few studies have examined HRV in TMD cases10, 81, 83. Two recent publications by
Schmidt and coworkers81 and Solberg Nes and coworkers 83 have examined the relationship
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between LF and HF variables and emotional reactivity and self-regulatory deficits in TMD
participants with masticatory pain. In the former study, TMD patients showed reduced HF
values at baseline and reduced levels during the recovery period following the recall of a
personally relevant negative life experience. In cases, LF values tended to be elevated at
baseline and were significantly elevated during the 10 min post-stress task recovery period.
The authors suggest that this profile in TMD cases is consistent with a compromised
inhibitory control of sympathetic activity resulting in prolonged increases in
cardiosympathetic and decreased cardioparasympathetic activity during rest and following
life-relevant psychological stressors. In a follow on study83, the relationship between HRV
and measures of “self regulatory strength”, which refers to one’s ability to exercise control,
guide and alter reactions and behaviors to environmental stimuli, was examined in a cohort
of FMS and TMD participants. Higher baseline HF values were associated with higher self
regulatory strength, which was indexed by the persistence in attempting to solve a difficult
cognitive problem. The association of higher HF with persistence was observed in control
participants and showed essentially no or minimal association in FMS and TMD cases.
Alterations of the LF band have also been observed in FMS cases under different conditions.
The LF band has been shown to be either increased or decreased in FMS under resting
conditions and in response to physical and psychological stressors.78, 79 The functional
interpretation of the relationship between the LF band and autonomic activity is
controversial. Historically, the LF band has been suggested to represent sympathetic cardiac
activation and the LF/HF ratio has been proposed as a parameter of cardiosympathovagal
balance.1, 6, 84 However, this historical view has been challenged because vagal blockade
with atropine reduces the spectral power in all frequency bands, including the LF band and
β1-adrenergic blockade produces ambiguous effects on specific bands of HR.6, 45 This has
led to a revised model where all frequency bands contribute to parasympathetic tone. As
such, the LF band and the LF/HF ratio are no longer viewed as valid indices of sympathetic
cardiac tone.6, 34
Collectively these findings, when taken in the context of current day understanding of the
functional significance of HRV, suggest that TMD is associated with reduced inhibitory
parasympathetic and excitatory sympathetic tone, but the overall autonomic balance and end
organ responses are biased towards the sympathetic nervous system, which is consistent
with the elevations in HR observed in TMD, FMS, and chronic myofascial pain at rest and
during physical and psychological stressors.68, 78, 79
Baroreceptor Sensitivity – TMD and Related Conditions
The relative reduction in LF values, increase in HR values, and increase in HR÷MAP Index
observed in TMD cases versus controls at rest and during orthostatic and Stroop procedures
suggests that TMD may be associated with impaired baroreceptor sensitivity, which
contributes to the relative sympathetic nervous system bias seen in TMD cases. The
outcomes of multiple studies have linked baroreceptor function to pain sensitivity and
psychological function.9, 56, 57, 59, 76–79 There is also evidence that chronic pain conditions,
including TMD, are associated with a baroreceptor mediated dysregulation of pain
perception. For example, TMD cases fail to show the typical relationship between resting
mean arterial BP, which is the primary physiological stimulus of the carotid sinus baroceptor
system, and pain perception.58 FMS is also associated with autonomic abnormalities that are
consistent with impairments in baroreceptor function.7, 13, 67, 70, 74 Recently Reyes Del Pase
et al78, 79 showed that baroreflex sensitivity is reduced in individuals with FMS at rest and
during physical and psychological stressors. They also demonstrated that the reduction in
baroreflex sensitivity is associated with reduced cardioparasympathetic tone, increased
resting heart rate and heart rate responses to physical and psychological stressors, as well as
enhanced clinical pain report and sensitivity to experimental pain stimulation. The observed
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reductions in HRV, baroreflex activity and elevations in HR are not only seen in TMD and
FMS patients, but appear to be a common feature associated with multiple complex
persistent pain conditions that are associated with somatic awareness.42
The increase in HR observed in TMD cases across all study conditions is also consistent
with diminished baroreflex sensitivity, which produces a cardiosympathetic bias and an
increase in HR.2, 24, 35, 90 The reduction in sympathetic tone, and associated decrease in
circulating catecholamines observed in FMS and TMD cases,15, 28, 31, 48, 52, 92 may result in
an upregulation and sensitization of β-adrenergic receptors such that when catecholamines
are released into the peripheral circulation augmented HR responses are evoked under
varying environmental conditions. Increases in circulating levels of catecholamines, such as
epinephrine, also enhance pain sensitivity and inflammatory responses by stimulating
peripheral nociceptors and suppressing the HPA axis via the stimulation of β-adrenergic
receptors.38–41
Implications for Treatment
The current findings suggest that pharmacological treatments that block the effects of
catecholamines should produce an analgesic effect in patients with TMD and related
conditions. Consistent with this view, the non-selective β-adrenoreceptor antagonist
propranolol and β2- and β3-adrenoreceptor selective antagonists reverse the mechanical and
thermal hyperalgesia and allodynia induced by catecholamines in rodent pain
models.38–40, 66 The blockade of β-adrenoreceptors with the non-selective β-adrenoreceptor
antagonist propranolol has also been shown to diminish clinical pain report in
subpopulations of patients with TMD that carry genetic variants of COMT coding for low
levels of enzyme.18, 52, 65, 87 It is also noteworthy that β-adrenoreceptor blockade with
propranolol reverses the suppression of the HPA axis resulting in an increase the secretion
of cortisol41 and enhances baroreflexes in man.17, 20, 24 These findings suggest that the
augmented sympathetic drive, which is indexed by increased HR and impaired baroreceptor
sensitivity, contributes to the clinical signs and symptoms seen in TMD and related
conditions and that β-adrenoreceptor antagonists, such as propranolol, may prove effective
in treating large subpopulations of TMD patients.
The current findings also suggest that non-pharmacological treatments that increase HRV
such as exercise23, breathing control11, 50, intraoral orthotics14 and interventions that
improve self regulatory strength83 may prove to be effective in treating TMD and related
conditions. As discussed by Schmidt and coworkers,81 and demonstrated by Lehrer and
coworkers49, 50, 89, biofeedback training using HRV increases vagal tone, parasympathetic
activation, and baroreflex gain. The degree to which manipulations that increase HRV and
baroreflex sensitivity are able to diminish pain and increase function in patients with TMD
and related conditions by restoring brainstem mediated inhibitory systems remains an open
and interesting question.
Age, Gender, and Race/Ethnicity -- Autonomic Profiles
Age—The observation that resting and stress-evoked changes result in arterial blood
pressure increase and HRV decrease as a function of age is consistent with previous
literature.3, 5, 32, 33, 47, 75, 93 Resting HR and HR values during physical and psychological
stressors were not associated with age and suggest that the observed elevations in arterial
blood pressure result from an age-dependency on α1-adrenoceptor mediated increases in
peripheral vascular resistance and/or arterial structural changes that produce arterial
stiffening. The observed age-dependent reduction in HRV is consistent with decreased
autonomic responses to physical and emotional stress and an age-dependent reduction in
baroreceptor sensitivity. While speculative, this autonomic profile may contribute to age-
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dependent increases in clinical pain conditions, clinical pain report and is consistent with the
observation that the prevalence of chronic TMD increases as a function of age (see Slade et
al. in this volume), at least in the restricted age range (18–44) studied in our OPPERA study.
Gender—The finding that females have lower arterial blood values, higher heart rate
values, and deceased HRV values at rest and during physical and psychological stressors is
consistent with multiple reports.5, 27, 43, 63, 85 The elevation in HR across experimental
conditions in females is consistent with the view that females show enhanced β-adrenergic
drive as a consequence of reduced baroreceptor sensitivity resulting in a cardiosympathetic
bias. The reduction in HRV in females is also consistent with attenuated autonomic
responses to physical and emotional stress. This profile is consistent with the observation
that females are generally more pain sensitive (see Greenspan et al. in this volume) and are
more likely to suffer from chronic TMD (see Slade et al. this volume) and related
conditions.
Race/Ethnicity—The observation that whites have lower arterial blood pressure and HR
reactivity to stressor as well as increased LF and VLF values compared to non-whites is
consistent with previous studies that have shown that African Americans have higher resting
arterial blood pressures, increased BP and HR responses to stress, and diminished
baroreceptor sensitivity compared to whites.4, 36, 44, 51, 64 In African Americans, this
autonomic profile is associated with both an increase in cardiosympathetic tone (β-
adrenergic mediated) and increased peripheral vascular resistance (α1-adrenergic mediated).
Based on the white vs non-white autonomic profiles one would predict that chronic TMD
and related conditions should be more prevalent in African American compared to whites.
Current experimental evidence provided by Plesh et al73 and Slade et al. (in this volume)
does not support this prediction, which suggest that unknown race/ethnicity specific genetic
and/or environmental factors produce protective effects in African Americans compared to
whites. One possible protective factor is the increase prevalence of hypertension in the
African American population, which may confer protective effects on the development of
chronic pain conditions.9, 25, 29, 30, 55, 56, 76
Latent Constructs Revealed by PCA—The various blood pressure measurements all
loaded on one component, as did all of the HR measurements. However, the HRV
measurements loaded on three different components, with each component corresponding to
a different epoch. This suggests that all the blood pressure measurements are highly
correlated with one another and that measuring blood pressure during different epochs
provides minimal additional information beyond the information obtained from measuring
blood pressure during a single epoch. Likewise, DBP and MAP provide minimal additional
information if SBP is known (and likewise for DBP and MAP). Similarly, if heart rate is
measured in one epoch, there is minimal information to be gained by measuring heart rate
during other epochs. One the other hand, the HRV measurements at baseline loaded on a
different component than the HRV measurements during the orthostatic challenge, and both
of these measurement sets loaded on a different component than the HRV measurements
during the Stroop procedures. This indicates that a person’s HRV at baseline is an imperfect
predictor of their HRV measurements during the orthostatic challenge or the Stroop
procedure and that we may gain additional information about a subject’s autonomic profile
by measuring their HRV in the three separate epochs.
Our PCA results should be viewed as exploratory, and further confirmation of these results
is necessary. A logical next step would be to attempt to reproduce these results in a future
study. If our model can be reproduced, these latent constructs identified by the model will be
a useful tool for future research. If several different measurements (i.e. systolic and diastolic
blood pressure in different epochs) are all strongly correlated measures of the same
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underlying construct, then it is likely that we can reduce the number of measurements
collected in future studies with minimal loss of information. These latent constructs may
also be evaluated as possible risk factors for new onset TMD.
Limitations
There are a few limitations that should be kept in mind. Given the size of the cohort, the
primary aims of OPPERA, and the need to develop a high throughput means of collecting
and analyzing HRV data, post-collection raw signal artifact assessment and correction was
not performed. Instead, the quality of the ECG signal was evaluated by staff during the
recording sessions and real-time artifact detection and rejection were conducted using
Biocom Heart Rhythm Scanner software. In addition, several steps were taken to review and
filter out-of -range values as described in the Methods section. A second limitation is that
we did not directly assess baroreflex sensitivity, but as noted above the LF band has been
shown to be a valid surrogate measure of baroreflex sensitivity. However, additional studies
are required that provide a more definitive assessment of the role that baroreflex function
plays in TMD and related conditions. Finally, it should be noted that many of the SOR’s
associated with case-status were relatively small, ranging from 1.2–2.2, which may
challenge the “clinical” meaningfulness of the findings. However, a variable with an odds
ratio of 1.2 could still be very important if it is approximately orthogonal to the other
measured variables. Additional multivariate modeling is required, and will be conducted in
the future, to more specifically address the relative importance of these variables, but
currently this is beyond the goals of the present analysis.
Conclusions and Future Directions
This is the first large-scale case-control study that has examined autonomic profiles in TMD
at rest and in response to physical and psychological stressors. TMD is associated with a
bias towards enhanced cardiosympathetic tone and a possible decrease in baroreflex
sensitivity, which is indexed by relatively low LF values at rest and during the application of
physical and psychological stressors. The clinical importance and causal relationship of
these findings as they relate to TMD onset and chronicity remain to be determined. Future
analyzes will examine the relationship between these findings and other phenotypic risk
factors and genetic polymorphisms. Finally, the OPPERA team intends to use the results of
this study to develop and validate cluster and multivariate models that represent explanatory
causal models that integrate putative risk determinates for TMD onset and chronicity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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This article reports autonomic findings from the OPPERA Study, a large prospective
cohort study designed to discover causal determinants of TMD pain. Findings indicate
statistically significant differences between TMD cases and controls across multiple
autonomic constructs at rest and during both physical and psychologically challenging
conditions. Future analyses will determine whether these autonomic factors increase risk
for new onset TMD.
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Scree plot and parallel analysis from PCA. The vertical lines depict the eigenvalues for each
component, showing a significant drop off after component 5. Also, the open triangles and
red line show the eigenvalues that would be expected for each component from a PCA
computed on a random data set. As can be seen, the observed eigenvalues for the first 5
components exceed the chance line, further supporting the selection of a 5 component
model.
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